Clinical significance of high-sensitivity c-reactive protein in Lifestyle-Related disease and metabolic syndrome

Journal of Cardiology

Volumn 50, Issue 3, 2007, Pages 175-182

  Hideki, ^a   Takeshi, ^a   Masaharu, ^b   Masunori, ^a   Yoshikane, H ^c  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Ozaki Junkankinaika   (Japan)

^c Yoshikane Junkankinaika   (Japan)

Author keywords

Diabetes mellitus; Diagnostic techniques (high sensitivity C reactive protein); Metabolism (metabolic syndrome); Risk factors

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE; LIFESTYLE AND RELATED PHENOMENA; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; METABOLIC SYNDROME X; OBESITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; WAIST CIRCUMFERENCE; BLOOD; COMPARATIVE STUDY; FEMALE; INTRAABDOMINAL FAT; MALE; MIDDLE AGED;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INTRA-ABDOMINAL FAT; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 38449101424     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979
2. Ross R : Atherosclerosis: An inflammatory disease. N EnglJ Med 1999; 340: 115-126
3. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143
4. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-843
5. Sakkien P, Abbott RD, Curb JD, Rodriguez BL, Yano K, Tracy RP: C-reactive protein and myocardial infarction. J Clin Epidemiol 2002; 55: 445-451
6. Ridker PM, Buring JE, Cook NR, Rifai N: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14719 initially healthy American women. Circulation 2003; 107: 391-397
7. Ridker PM: High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: From concept to clinical practice to clinical benefit. Am Heart J 2004; 148: S19-S26
8. Cushman MC, Arnold AM, Psaty BM, Manolio TA, Kuller LH, Burke GL, Polak JF, Tracy RP: C-reactive protein and the 10-year incidence of coronary heart disease in older men and women : The cardiovascular health study. Circulation 2005; 112: 25-31
9. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention; American Heart Association: Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511
10. Japanes Saurce 2005; 94: 794-809
11. Yamada S, Gotoh T, Nakashima Y, Kayaba K, Ishikawa S, Nago N, Nakamura Y, Itoh Y, Kajii E: Distribution of serum C-reactive protein and its association with athero-sclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol 2001; 153: 1183-1190
12. Ichihara Y, Ohno J, Suzuki M, Anno T, Sugino M, Nagata K: Higher C-reactive protein concentration and white blood cell count in subjects with more coronary risk factors and/or lower physical fitness among apparently healthy Japanese. CircJ 2002; 66: 677-684
13. Saito I, Yonemasu K, Inami F: Association of body mass index, body fat, and weight gain with inflammation markers among rural residents in Japan. Circ J 2003; 67: 323-329
14. Nakanishi N, Shiraishi T, Wada M: C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men : The Minoh Study. Circ J 2005; 69: 386-391
15. Ishikawa S, Kayaba K, Gotoh T, Nakamura Y, Kajii E: Metabolic syndrome and C-reactive protein in the general population: JMS Cohort Study. Circ J 2007; 71: 26-31
16. Plenge JK, Hernandez TL, Weil KM, Poirier P, Grunwald GK, Marcovina SM, Eckel RH: Simvastain lowers C-reactive protein within 14 days: An effect independent of low-density lipoprotein cholesterol reduction. Circulation 2002; 106: 1447-1452
17. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LN, McCabe CH, Pfeffer MA, Braunwald E, for the Pravastatin or Atorvastain Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators: C-reactive protein levels and outcomes after stain therapy. N Engl J Med 2005; 352: 20-28
18. Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, Orazem J, Magorien RD, O'Shaughnessy C, Ganz P, for The Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVESAL) Inveatigators: Stain therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005; 352: 29-38
19. Schieffer B, Biinte C, Witte J, Hoeper K, Boger RH, Schwedhelm E, Drexler H: Comparative effects of ATI-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease. J Am Coll Cardiol 2004; 44: 362-368
20. Ridker PM, Danielson E, Rifai N, Glynn RJ, for the Val-MARC Investigators: Valsartan, blood pressure reduction, and C-reactive protein: Primary report of the Val-MARC trial. Hypertention 2006: 48: 73-79
21. NestoR: C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones. DiabetMed2004; 21: 810-817
22. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J: Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414-419
23. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F ; American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752
24. Nakamura T, Tsubono Y, Kameda-Takemura K, Funahashi T, Yamashita S, Hisamichi S, Kita T, Yamamura T, Matsuzawa Y, for the Group of the Research for the Association between Host Origin and Atherosclerotic Diseases under the Preventive Measure for Work-related Diseases of the Japanese Labor Ministry: Magnitude of sustained multiple risk factors for ischemic heart disease in Japanese employees: A case-control study. Jpn Circ J 2001; 65: 11-17